RDN was performed according to a standardized protocol, as described previously.10 , 11 In brief, repeated ablation runs were delivered to each renal artery. The ablation points were placed circumferentially to the renal artery wall from distal to proximal. All patients received intravenous remifentanil to control visceral pain. Overall, 83 patients underwent ablation with a Symplicity Flex catheter, 21 patients were treated with Spyral catheters (both from Medtronic), and 27 patients underwent ablation with an ultrasound‐based denervation system (Paradise; ReCor Medical).
Symplicity flex catheter
Manufactured by Medtronic
Sourced in United States
The Symplicity Flex catheter is a medical device designed for use in diagnostic procedures. It is intended to facilitate the measurement and assessment of various physiological parameters. The core function of the Symplicity Flex catheter is to collect data, without interpretation or extrapolation on its intended use.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using symplicity flex catheter
1
Standardized Renal Denervation Procedure
2
Renal Denervation Procedure Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Patients received peri-procedural analgesia and conscious sedation with propofol/midazolam and remifentanil intravenous perfusion. Anti-thrombotic treatment included aspirin and a bolus of weight-adjusted unfractioned heparin (70–100 U/Kg). Femoral arterial access was obtained with 6F or 8F sheaths. Radiofrequency energy was delivered using the single-tip radiofrequency Symplicity Flex catheter (Medtronic Inc., Santa Rosa, CA, USA), the EnligHTN system (St. Jude Medical, MN, USA), or the Symplicity Spyral catheter (Medtronic Inc., Santa Rosa, CA, USA) in 9.5%, 38.1%, and 52.4% of the patients, respectively. Energy was applied to the main artery and branches, when feasible and according to the characteristics of each device with the goal of achieving a maximum number of circumferential ablation points. Radiofrequency energy was delivered according to a programmed algorithm specific to each device. Administration of intra-renal nitrates and a final renal angiogram was performed. All procedures were conducted by one interventional cardiologist dedicated to the field. Hemostasis was accomplished with a vascular closure device. All patients were monitored for 24 h before discharge.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!